Mpm Bioimpact LLC’s Agios Pharmaceuticals Inc Position
Does Mpm Bioimpact LLC own Agios Pharmaceuticals Inc (AGIO)? Yes — 1.31M shares worth $44M (+3.41% of its 13F portfolio) as of Q1 2026, up from 1.30M shares the prior filed quarter.
Position Value
$44M
Q1 2026
Shares
1.31M
% of Portfolio
+3.41%
Quarters Held
2
currently held
Position History AGIO
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mpm Bioimpact LLC’s full portfolio or all institutional holders of AGIO.